Ovid Therapeutics Inc.
USD2.72
+0.17 (+6.67%)
CEO
Margaret Alexander
IPO Date
2017-05-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.53
Prev. Close
$2.55
Day Low
$2.48
Day High
$2.73
52W Low
$0.30
52W High
$3.10
Market Cap
$0.36B
Volume
1.52M
| -2.5 |
| 31 Dec 2023 | FY | 100.0% | -13351.8% | -59.6% | -36.3% | 0.18 | 9.55 | -4.3 |
| 31 Dec 2022 | FY | 100.0% | -3604.7% | -41.0% | -34.9% | 0.13 | 18.79 | -2.4 |
| 31 Dec 2021 | FY | 100.0% | 58.9% | 68.3% | 63.1% | 0.00 | 12.87 | 1.8 |
| 31 Dec 2020 | FY | 100.0% | -642.3% | -185.7% | -106.7% | 0.00 | 3.39 | -1.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -86.3% | -74.8% | 0.00 | 7.58 | -2.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -134.0% | -109.1% | 0.00 | 5.01 | -1.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -77.7% | -72.4% | 0.00 | 14.71 | -2.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -45.5% | -42.3% | 0.00 | 14.04 | -10.7 |
| 3.4 |
| 30 Sept 2025 | Q3 | 100.0% | -9210.6% | -27.2% | -19.0% | 0.31 | 4.24 | -1.9 |
| 30 Jun 2025 | Q2 | 100.0% | -74.7% | -8.4% | -6.0% | 0.25 | 4.72 | -1.3 |
| 31 Mar 2025 | Q1 | 100.0% | -7873.1% | -17.3% | -12.5% | 0.24 | 4.93 | -0.5 |
| 31 Dec 2024 | Q4 | 100.0% | -12175.0% | -13.6% | -10.0% | 0.22 | 5.32 | -1.8 |
| 30 Sept 2024 | Q3 | 100.0% | -8096.0% | -18.4% | -13.6% | 0.20 | 5.66 | -1.5 |
| 30 Jun 2024 | Q2 | 100.0% | 5042.0% | 9.6% | 7.2% | 0.18 | 5.73 | 1.8 |
| 31 Mar 2024 | Q1 | 100.0% | -7901.4% | -14.9% | -8.9% | 0.20 | 10.47 | -4.7 |
| 31 Dec 2023 | Q4 | 100.0% | -10790.1% | -17.5% | -10.6% | 0.18 | 9.55 | -3.7 |